ClassID:

21488

A61K49/126 - CPC Classification

Classification description:

Preparations for testing; Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier; Organic compounds; Macromolecular compounds Linear polymers, e.g. dextran, inulin, PEG

Sub-classes:
Recent Application in this class:
#1
20260144901
2026-05-28

CUSTOMIZABLE LYOPHILIZED AGENT FOR IMAGE-GUIDED RADIOTHERAPY AND DRUG DELIVERY

#2
20250325714
2025-10-23

SINGLE-POLYMER PARTICLES, ACTIVE MOLECULAR COMPLEX, METHOD FOR PRODUCING SINGLE-POLYMER PARTICLES, METHOD FOR MEASURING TUMOR SIZE, METHOD FOR MEASURING FINE STRUCTURE WITHIN TUMOR, METHOD FOR IMAGING BIOLOGICAL TISSUE, DRUG DELIVERY SYSTEM, AND CONTRAST AGENT KIT

#3
20250276099
2025-09-04

MRI CONTRAST AGENT INCLUDING T1 CONTRAST MATERIAL COATED ON SURFACE OF NANOPARTICLE SUPPORT

#4
20250000384
2025-01-02

METHODS FOR MAGNETIC RESONANCE IMAGING OF NANOCONSTRUCTS AND USES THEREOF

#5
20240374763
2024-11-14

DIAGNOSIS AND MONITORING USING EXTRADOMAIN-B FIBRONECTIN TARGETED PROBES

#6
20240316225
2024-09-26

SYNTHETIC CYCLIC PEPTIDE MIMETICS

#7
20240262942
2024-08-08

Injection Molded Medical Devices Made From A High Molecular Weight Polyethylene

#8
20240082434
2024-03-14

CONTRAST AGENTS, METHODS FOR PREPARING CONTRAST AGENTS, AND METHODS OF IMAGING

#9
20230338586
2023-10-26

MULTIFUNCTIONAL CONTRAST AGENTS, COMPOSITIONS, AND METHODS

#10
20230057249
2023-02-23

TARGETED PROTEIN CONTRAST AGENTS, METHODS OF MAKING, AND USES THEREOF

#11
20220080057
2022-03-17

Biocompatible magnetic materials

#12
20220016270
2022-01-20

Radiopaque monomers, polymers, microspheres, and methods related thereto

#13
20210170055
2021-06-10

TARGETED CONTRAST AGENTS FOR MRI OF AMYLOID DEPOSITION

#14
20210113717
2021-04-22

MRI CONTRAST AGENT INCLUDING T1 CONTRAST MATERIAL COATED ON SURFACE OF NANOPARTICLE SUPPORT

#15
20210113715
2021-04-22

TARGETED NANOPARTICLES FOR DIAGNOSING, DETECTING AND TREATING CANCER

#16
20210060184
2021-03-04

Methods and compositions for deuterated biologics

#17
20210038746
2021-02-11

Targeted protein contrast agents, methods of making, and uses thereof

#18
20210038745
2021-02-11

Contrast agents, methods for preparing contrast agents, and methods of imaging

#19
20200397925
2020-12-24

Targeted protein contrast agents, methods of making, and uses thereof

#20
20200308319
2020-10-01

Injection molded medical devices made from a high molecular weight polyethylene

#21
20200222560
2020-07-16

Development of injectable fiducial markers for image guided radiotherapy with dual MRI and CT visibility

#22
20200179540
2020-06-11

MRI imaging of amyloid plaque using liposomes

#23
20200069820
2020-03-05

MRI IMAGING OF AMYLOID PLAQUE USING LIPOSOMES

#24
20190381195
2019-12-19

Conjugated polymer-based nanoprobe and preparation method and application thereof

#25
20190282713
2019-09-19

Imaging compositions

#26
20190247522
2019-08-15

BIOCOMPATIBLE MAGNETIC MATERIALS

#27
20190231908
2019-08-01

Radiopaque monomers, polymers, microspheres, and methods related thereto

#28
20180318455
2018-11-08

COMPLEXES BETWEEN BLOCK POLYMERS AND IONS AS CONTRAST AGENTS FOR MEDICAL IMAGING

#29
20180280544
2018-10-04

Targeted protein contrast agents, methods of making, and uses thereof

#30
20180250426
2018-09-06

Contrast agents, methods for preparing contrast agents, and methods of imaging

#31
20180085496
2018-03-29

FERROMAGNETIC PARTICLES BOUND TO POLYMERIC IMPLANTS

#32
20180008753
2018-01-11

SIDE-CHAIN CRYSTALLIZABLE POLYMERS FOR MEDICAL APPLICATIONS

#33
20170196997
2017-07-13

RARE EARTH-BASED NANOPARTICLE MAGNETIC RESONANCE CONTRAST AGENT AND PREPARATION METHOD THEREOF

#34
20170189560
2017-07-06

Glucose conjugated gold nanoparticle

#35
20170181979
2017-06-29

PROCESS FOR PRODUCING NANOPARTICLES

#36
20170080112
2017-03-23

MAGNETIC AND FLUORESCENT REVERSE NANOASSEMBLIES

#37
20170080111
2017-03-23

MRI imaging of amyloid plaque using liposomes

#38
20160296642
2016-10-13

Compositions and Methods to Image and Quantify Inflammation

#39
20160263253
2016-09-15

Suicide contrast agents targeting HIV reservoirs for theranostic eradication

#40
20160220705
2016-08-04

Biodegradable organic radical-functionalized polycarbonates for medical applications

#41
20160200670
2016-07-14

Radiopaque monomers, polymers, microspheres, and methods related thereto

#42
20160101197
2016-04-14

MRI imaging of amyloid plaque using liposomes

#43
20160089455
2016-03-31

MRI contrasting agent for contrasting cancer cell

#44
20160089436
2016-03-31

Self-assembled pharmaceutical composition for photodynamic therapy

#45
20160051709
2016-02-25

COMPOSITION-CONTROLLED NOBLE METAL-TRANSITION METAL SMALL NANOPARTICLE ALLOYS WITH NIR-EMISSION AND HIGH T2 RELAXIVITY AND METHOD FOR MAKING SAME

#46
20160008492
2016-01-14

COMPOSITIONS OF SACCHARIDE COATED NANOPARTICLES AND USES

#47
20160000942
2016-01-07

MRI CONTRAST AGENT INCLUDING T1 CONTRAST MATERIAL COATED ON SURFACE OF NANOPARTICLE SUPPORT

#48
20150352232
2015-12-10

MR IMAGING DIAGNOSTIC AGENT FOR INTRACTABLE NEUROLOGICAL DISEASE

#49
20150320890
2015-11-12

NANOPARTICLES FOR BRAIN TUMOR IMAGING

#50
20150265728
2015-09-24

Magnetic and fluorescent reverse nanoassemblies

#51
20150258222
2015-09-17

Magnetic nanoparticles

#52
20150258034
2015-09-17

Gold/lanthanide nanoparticle conjugates and uses thereof

#53
20150247008
2015-09-03

Chelating amphiphilic polymers

#54
20150196583
2015-07-16

Compounds and their effects on appetite control and insulin sensitivity

#55
20150190553
2015-07-09

Embolic devices

#56
20150139914
2015-05-21

Contrast agent for nuclear magnetic resonance imaging comprising melanin nanoparticles stably dispersed in water

#57
20150079005
2015-03-19

Polymeric nanocarriers with linear dual response mechanism

#58
20150071861
2015-03-12

Polymer, contrast agent for nuclear magnetic resonance analysis or magnetic resonance imaging using the polymer, compound and method of nuclear magnetic resonance analysis and method of magnetic resonance imaging using the polymer

#59
20150004097
2015-01-01

MMP-TARGETED THERAPEUTIC AND/OR DIAGNOSTIC NANOCARRIERS

#60
20140377175
2014-12-25

Chemically-linked nanoparticles

#61
20140356283
2014-12-04

Probes, Methods of Making Probes, and Methods of Use

#62
20140328768
2014-11-06

Iron oxide nanocapsule, method of manufacturing the same, and MRI contrast agent using the same

#63
20140302324
2014-10-09

MRI-visible hydrophobic copolymer

#64
20140296509
2014-10-02

Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents

#65
20140234223
2014-08-21

NANOEMULSIONS AND USE THEREOF AS CONTRAST AGENTS

#66
20140178310
2014-06-26

Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents

#67
20140178300
2014-06-26

Theranostic imaging agents and methods of use

#68
20140170077
2014-06-19

High-sensitivity magnetic resonance imaging nano-contrast agent based on an anionic polymer and cationic polymer ion complex, and a production method therefor

#69
20140086846
2014-03-27

Contrast enhancement agents and method of use thereof

#70
20140065076
2014-03-06

CONTAINER WITH CONCENTRATED SUBSTANCE AND METHOD OF USING THE SAME

#71
20130302258
2013-11-14

MRI contrast agents

#72
20130302251
2013-11-14

Embolic devices

#73
20130216480
2013-08-22

AMPHIPHILIC POLYMERS AND METHODS OF USE THEREOF

#74
20130195758
2013-08-01

PAA nanoplatforms containing fluorophores and targeted moieties covalently linked and photosensitizer post-loaded

#75
20130011340
2013-01-10

Compositions and methods comprising magnetic resonance contrast agents

#76
20120207681
2012-08-16

CHEMICAL COMPOSITIONS TO DETECT AND TREAT AMYLOID IN A PATIENTS BRAIN AND RETINA

#77
20120190793
2012-07-26

METHOD FOR THE PRODUCTION OF SCAFFOLDS FOR TISSUE ENGINEERING, COMPRISING THE USEOF AN ANCHORING UNIT, AND SCAFFOLD PRODUCED THEREWITH

#78
20120177578
2012-07-12

Compositions, methods, and systems comprising fluorous-soluble polymers

#79
20120148500
2012-06-14

Use of a fluorinated polymer as a contrast agent in solid state 19F magnetic resonance imaging (MRI), scaffold comprising said polymer and use thereof

#80
20120114564
2012-05-10

MRI T1 CONTRASTING AGENT COMPRISING MANGANESE OXIDE NANOPARTICLE

#81
20120093725
2012-04-19

Fucoidans as Ligands for the Diagnosis of Degenerative Pathologies

#82
20120070383
2012-03-22

Polymeric nano-carriers with a linear dual response mechanism and uses thereof

#83
20120052006
2012-03-01

Gold/lanthanide nanoparticle conjugates and uses thereof

#84
20120021450
2012-01-26

METHODS FOR MAGNETIC RESONANCE IMAGING

#85
20110250138
2011-10-13

SINGLE-STRANDED AND DOUBLE-STRANDED OLIGONUCLEOTIDES COMPRISING A METAL-CHELATING LIGAND

#86
20110218331
2011-09-08

Method of Preparation of DTPA Crosslinked Hyaluronic Acid Derivatives and Modification of Said Dervivatives

#87
20110213456
2011-09-01

Side-chain crystallizable polymers for medical applications

#88
20110208040
2011-08-25

Molecular imaging

#89
20110165074
2011-07-07

Chelating amphiphilic polymers

#90
20110144054
2011-06-16

Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents

#91
20110142787
2011-06-16

Polymerized cyclic nitroxide radical compound and use thereof

#92
20110129421
2011-06-02

MATRIX METALLOPROTEASE TARGETING NUCLEIC ACIDS

#93
20110104261
2011-05-05

REMOTE DETECTION OF SUBSTANCE DELIVERY TO CELLS

#94
20110097742
2011-04-28

CONTRAST AGENTS, METHODS FOR PREPARING CONTRAST AGENTS, AND METHODS OF IMAGING

#95
20110021745
2011-01-27

ULTRA-SMALL CHITOSAN NANOPARTICLES USEFUL AS BIOIMAGING AGENTS AND METHODS OF MAKING SAME

#96
20100278737
2010-11-04

Organic-inorganic hybrid particles containing contrast agent

#97
20100260686
2010-10-14

Nanoparticles for brain tumor imaging

#98
20100239504
2010-09-23

IMAGING NUCLEIC ACID BINDING PROTEINS

#99
20100163778
2010-07-01

Simple method for introducing magnetic particles into a polymer

#100
20090074673
2009-03-19

Compositions and methods for producing cellular labels for nuclear magnetic resonance techniques

#101
20090048331
2009-02-19

METHODS AND FORMULATIONS FOR THE DELIVERY OF PHARMACOLOGICALLY ACTIVE AGENTS

#102
20080200373
2008-08-21

Multi-component biological transport systems

#103
20080159954
2008-07-03

Metal chelates having a perfluorinated PEG radical, processes for their preparation, and their use

#104
20080118440
2008-05-22

Imaging Cellular Nucleic Acids

#105
20080014149
2008-01-17

Methods and Compositions for Imaging and Biomedical Applications

#106
20070253899
2007-11-01

Dual function polymer micelles

#107
20070189966
2007-08-16

Diagnostic agents for pancreatic exocrine function

#108
20070154398
2007-07-05

Block copolymers and nano micelles comprising the same

#109
20070154396
2007-07-05

Block copolymers and nano micelles comprising the same

#110
20060269479
2006-11-30

Amphiphilic polymers and methods of use thereof

#111
20060182779
2006-08-17

Side-chain crystallizable polymers for medical applications

#112
20060025378
2006-02-02

Dose dependent elimination of HA and cell receptor stimulation

#113
20060024662
2006-02-02

Methods for magnetic resonance imaging

#114
20050232866
2005-10-20

Biochemically-activated contrast agents for magnetic resonance imaging

#115
20050152842
2005-07-14

Poly (L-glutamic acid) paramagnetic material complex and use as a biodegradable MRI contrast agent

#116
20050112065
2005-05-26

Remote detection of substance delivery to cells

#117
20050032148
2005-02-10

Diagnostic agents for pancreatic exocrine function

#118
20050019253
2005-01-27

Diagnostic agents for pancreatic exocrine function

#119
20050019252
2005-01-27

Diagnostic agents for pancreatic exocrine function

#120
20050008570
2005-01-13

Hydroxypyridonate and hydroxypyrimidinone chelating agents

#121
15907703
2019-07-09

Micro/nano magnetic hydrogels with autofluorescence for therapeutic and diagnostic applications